CellaVision

Banner image with text: 'Stay informed with the latest IP news' and the following words listed: Insights, Interviews, Webinars.

CellaVision acquires exclusive rights to novel microscopy technology

By AWA | Posted on April 8, 2021

AWA’s client CellaVision has signed an agreement to acquire the exclusive rights to a patent portfolio on Fourier Ptychographic Microscopy, a novel microscopy technology from Clearbridge BioPhotonics. CellaVision is an innovative, global medical technology company that develops and sells leading systems for routine analysis of blood and other body fluids in health care services. AWA...

Read more : CellaVision acquires exclusive rights to novel microscopy technology

Filed under: Insights

Tags: CellaVision, due dilligence, patents

Recent contributors

Anders Heebøll-Nielsen, Partner and European Patent Attorney, Copenhagen, Denmark

Anders Heebøll-Nielsen

Partner, European Patent Attorney, Certified Danish Patent Agent

Ashley Zhao, Partner and Attorney at Law, Beijing, China

Ashley Zhao

Partner, Attorney at Law, Business Area Manager

Monika Trombitas Andersson, Associate and Attorney at Law, Lund, Sweden

Monika Trombitas Andersson

Associate, Attorney at Law, European Trademark and Design Attorney

Emily Chamberlain, Senior Associate and Patents, Stockholm, Sweden

Emily Chamberlain

Senior Associate, Patents

Niklas Mattsson, Partner and European Patent Attorney, Stockholm, Sweden

Niklas Mattsson

Partner, European Patent Attorney, Authorised Swedish Patent Attorney, UPC Representative

Ai-Leen Lim, Partner and Attorney at Law, Hong Kong SAR

Ai-Leen Lim

Partner, Attorney at Law, Group Vice President